Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Idiopathic overactive bladder and BOTOX(®): Literature review].
Gamé X, Karsenty G, Ruffion A, Amarenco G, Ballanger P, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Haab F, Hermieu JF, Le Normand L, Saussine C, Denys P. Gamé X, et al. Among authors: ballanger p. Prog Urol. 2015 Jun;25(8):461-73. doi: 10.1016/j.purol.2015.01.006. Epub 2015 Feb 3. Prog Urol. 2015. PMID: 25662706 Review. French.
[Sacral neuromodulation with InterStim™ system: Results from the French national register].
Chartier-Kastler E, Ballanger P, Belas M, Biserte J, Corbel L, Gamé X, Grise P, Karsenty G, Le Normand L, Mauroy B, Pasquale J, Ruffion A, Rousseau T, Saussine C, Suberville M, Tollon C; club de neuromodulation de l'Association française d'urologie. Chartier-Kastler E, et al. Among authors: ballanger p. Prog Urol. 2011 Mar;21(3):209-17. doi: 10.1016/j.purol.2010.05.008. Prog Urol. 2011. PMID: 21354040 Clinical Trial. French.
[Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management].
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Saussine C. Hermieu JF, et al. Among authors: ballanger p. Prog Urol. 2013 Dec;23(17):1457-63. doi: 10.1016/j.purol.2013.10.006. Epub 2013 Nov 7. Prog Urol. 2013. PMID: 24286546 Free article. French.
[Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome].
Deffieux X, Fatton B, Denys P, Chartier-Kastler E, Amarenco G, Haab F, Costa P, Game X, Karsenty G, Saussine C, Ballanger P, Le Normand L, Ruffion A, Hermieu JF, Cosson M. Deffieux X, et al. Among authors: ballanger p. J Gynecol Obstet Biol Reprod (Paris). 2014 Oct;43(8):572-80. doi: 10.1016/j.jgyn.2014.06.011. Epub 2014 Jul 30. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 25087018 French.
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations.
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler É, Cosson M, Costa P, Fatton B, Saussine C, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Deffieux X. Hermieu JF, et al. Among authors: ballanger p. Prog Urol. 2014 Sep;24(11):e1-7. doi: 10.1016/j.purol.2014.06.005. Epub 2014 Jul 9. Prog Urol. 2014. PMID: 25214455 Free article.
[Synthesis of the guidelines for the treatment of non-neurological urinary incontinence in women].
Hermieu JF, Conquy S, Leriche B, Debodinance P, Delorme E, Boccon Gibod L, Cortesse A, Vidart A, Cour F, Richard F, Cardot V, Berlizot P, Lenormand L, Ragni E, Peyrat L, Yiou R, Ballanger P; Comité d'Urologie et de Pelvipérinéologie de la Femme (Association Française d'Urologie). Hermieu JF, et al. Among authors: ballanger p. Prog Urol. 2010 Feb;20 Suppl 2:S94-9. doi: 10.1016/S1166-7087(10)70002-6. Prog Urol. 2010. PMID: 20403574 French.
[Urinary stones in subjects over the age of sixty].
Neuzillet Y, Lechevallier E, Ballanger P, Ferriere JM, Saussine C, Doré B, Conort P. Neuzillet Y, et al. Among authors: ballanger p. Prog Urol. 2004 Sep;14(4):479-84. Prog Urol. 2004. PMID: 15776895 French.
Efficacité et tolérance des injections intra-prostatique de toxine botulique dans le traitement de l'hyperplasie bénigne de prostate symptomatique : PHRC national PROTOX.
Robert G, Delongchamps NB, Descazeaud A, Bénard A, Azzouzi R, Saussine C, De la Taille A, Fourmarier M, Karsenty G, Desgrandchamps F, Faix A, Pasticier G, Bernhard J, Ferrière J, Ballanger P. Robert G, et al. Among authors: ballanger p. Prog Urol. 2015 Nov;25(13):853-4. doi: 10.1016/j.purol.2015.08.276. Prog Urol. 2015. PMID: 26544470 French. No abstract available.
Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent men.
Chartier-Kastler E, Ballanger P, Petit J, Fourmarier M, Bart S, Ragni-Ghazarossian E, Ruffion A, Le Normand L, Costa P. Chartier-Kastler E, et al. Among authors: ballanger p. BJU Int. 2011 Jul;108(2):241-7. doi: 10.1111/j.1464-410X.2010.09736.x. Epub 2010 Oct 15. BJU Int. 2011. PMID: 20950307 Clinical Trial.
125 results